Masahiro Nishimoto

This inventor holds 21 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 3 EPO patents, primarily in Diabetes Treatment. Top assignee: Chugai Seiyaku Kabushiki Kaisha. Active years: 2003-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Masahiro Nishimoto. Retrieved from https://idiyas.com/inventor/masahiro-nishimoto

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 21 (Patent Applications = 3)

% Patents Active = 38.1

CIPO Patents = 1

EPO Patents = 3 (Patent Applications = 1)

Average Co-Inventor Count = 8.5

ph-index = 5

Forward Citations = 71(Granted Patents)

Location History:

Mishima, JP (2003)
Mishima, KR (2006)
Susono, JP (2007 - 2010)
Gotenba, JP (2010 - 2012)
Shizuoka, JP (2003 - 2023)

Company Filing History:

21 out of 991

Chugai Seiyaku Kabushiki Kaisha

patents

Years Active: 2003-2025

Loading Chart...

Areas of Expertise:

GLP-1 Receptor Agonist

Pyrazolopyridine Derivative

Anti-Diabetic Drug

Malonyl-CoA Decarboxylase Inhibitor

Therapeutic Agent

Spiroketal Derivative

Benzopyran Derivative

Optically Active Chroman

Metabolic Modulators

Prodrug

Fused Ring Compound

Hydroxycarbonyl-Halogenoalkyl

21 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12410168 - Pyrazolopyridine derivative having GLP-1 receptor agonist effect (2025-09-09),

2. 12331050 - Pyrazolopyridine derivative having GLP-1 receptor agonist effect (2025-06-17),

3. 12331049 - Pyrazolopyridine derivative having GLP-1 receptor agonist effect (2025-06-17),

4. RE50455 - Pyrazolopyridine derivative having GLP-1 receptor agonist effect (2025-06-10),

5. 12187724 - Pyrazolopyridine derivative having GLP-1 receptor agonist effect (2025-01-07),

6. 11814381 - Pyrazolopyridine derivative having GLP-1 receptor agonist effect (2023-11-14),

7. 10858356 - Pyrazolopyridine derivative having GLP-1 receptor agonist effect (2020-12-08),

8. 8207134 - Fused ring spiroketal derivative and use thereof as anti-diabetic drug (2012-06-26),

9. 8048897 - Cyclohexane derivative, prodrug thereof and salt thereof, and therapeutic agent containing the same for diabetes (2011-11-01),

10. 7943748 - Glucitol derivative, prodrug thereof and salt thereof, and therapeutic agent containing the same for diabetes (2011-05-17),

11. 7767651 - Spiroketal derivatives and use thereof as diabetic medicine (2010-08-03),

12. 7723366 - Azole compounds as malonyl-CoA decarboxylase inhibitors for treating metabolic diseases (2010-05-25),

13. 7279477 - Malonyl-CoA decarboxylase inhibitors useful as metabolic modulators (2007-10-09),

14. 7196081 - Compounds with hydroxycarbonyl-halogenoalkyl side chains (2007-03-27),

15. 7074819 - Benzopyran or thiobenzopyran derivatives (2006-07-11),

Title: The Innovative Journey of Masahiro Nishimoto

Introduction:

Masahiro Nishimoto is a pioneering inventor hailing from Shizuoka, Japan. With a passion for creating groundbreaking solutions, he has made significant contributions to the field of technology through his inventive spirit and dedication.

Latest Patents:

Masahiro Nishimoto's latest patents focus on advancements in robotics and artificial intelligence, showcasing his commitment to pushing the boundaries of innovation in these fields.

Career Highlights:

Throughout his illustrious career, Masahiro Nishimoto has been recognized for his innovative approach to problem-solving. His work has led to the development of cutting-edge technologies that have revolutionized industries and improved the lives of many.

Collaborations:

Masahiro Nishimoto has collaborated with leading research institutions and tech companies to bring his inventions to life. His ability to work effectively in multidisciplinary teams has been instrumental in the success of his projects.

Conclusion:

In conclusion, Masahiro Nishimoto stands as a visionary inventor whose work continues to inspire and shape the future of technology. His relentless pursuit of innovation and excellence sets him apart as a true trailblazer in the world of inventions.

Profile summary based on public USPTO records.